Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Research Site, Randwick

Research Site, Melbourne

Research Site, New York

Research Site, Cologne

Research Site, Houston

Research Site, Los Angeles

Research Site, San Francisco

Research Site, Boston

Research Site, Melbourne, Parkville

Research Site, Hospitalet deLlobregat

Research Site, Lund